MS disease modifying therapy approvals 'to double by 2021'

If it's on your mind and it has to do with multiple sclerosis in any way, post it here.

MS disease modifying therapy approvals 'to double by 2021'

Postby MSUK » Tue Oct 23, 2012 4:38 am

Image

The number of disease-modifying therapies (DMT) approved for the treatment of multiple sclerosis (MS) is expected to double to 2021, and this will intensify market fragmentation, according to new forecasts.

In this new era of enhanced therapeutic potential and complex treatment choices, fragmentation of the world's leading markets - France, Germany, Italy, Japan, Spain, the UK and the US - will intensify, as the MS field strives towards a more individualised approach to treatment, says the study, from Decision Resources.

Investigational MS therapies comprise a diverse mix of oral and parenteral agents, novel compounds, next-generation products and reformulations, the study points out. Among the new oral agents which are expected to launch during this time, Biogen Idec's oral immunomodulator BG-12 will have the greatest commercial success, with major-market sales of around $3 billion in 2017 as a result of clinical data that support a highly-favourable risk/benefit profile, Decision Resources forecasts.

Also in 2017, Novartis/Mitsubishi Tanabe Pharma's first-to-market oral agent Gilenya/Imusera (fingolimod) is expected to produce sales exceeding $2 billion in these major markets. However, other emerging oral competitors - including Sanofi/Genzyme's Aubagio (teriflunomide), which recently launched in the US - are not expecting to achieve blockbuster status, owning to more limited clinical advantages, it says.... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/2479
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 1981
Joined: Wed Oct 14, 2009 3:00 pm

Advertisement

Re: MS disease modifying therapy approvals 'to double by 201

Postby euphoniaa » Tue Oct 23, 2012 9:34 am

squiffy2 wrote:Image

The number of disease-modifying therapies (DMT) approved for the treatment of multiple sclerosis (MS) is expected to double to 2021, and this will intensify market fragmentation, according to new forecasts.

Awww, bummer, it looks like the Subject Heading should read "double by 2021" and not by 2012. :-D
Dx'd with MS & HNPP (hereditary peripheral neuropathy) 7/03 but must have had MS for 30 yrs before that. I've never taken meds for MS or MS symptoms except 1 yr experiment on LDN. (I found diet, exercise, sleep, humor, music help me the most.)
User avatar
euphoniaa
Family Elder
 
Posts: 659
Joined: Sat Jul 15, 2006 3:00 pm
Location: midwest U.S.

Re: MS disease modifying therapy approvals 'to double by 201

Postby PointsNorth » Tue Oct 23, 2012 9:49 am

Since CCSVI, my neuros have been pushing DMDs extra hard. I wonder if others have experienced the same? 10 years ago I researched my DMD options and decided not to bite. I'm learning to trust my judgement!
Albany 2010. Brooklyn 2011
Hurry up and wait.
PointsNorth
Family Elder
 
Posts: 489
Joined: Mon Sep 04, 2006 3:00 pm
Location: LeftCoast Canada

Re: MS disease modifying therapy approvals 'to double by 202

Postby CureOrBust » Wed Oct 24, 2012 3:16 am

The number of disease-modifying therapies (DMT) approved for the treatment of multiple sclerosis (MS) is expected to double to 2021, and this will intensify market fragmentation, according to new forecasts.
do these same forecasters have a date for a cure... :evil:
User avatar
CureOrBust
Family Elder
 
Posts: 2871
Joined: Wed Jul 27, 2005 3:00 pm
Location: Sydney, Australia


Return to General Discussion

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users